191 related articles for article (PubMed ID: 20602330)
1. Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.
Mu J; Feng B; Ye Z; Yuan F; Zeng W; Luo Z; Qi W
J Nephrol; 2011; 24(2):177-84. PubMed ID: 20602330
[TBL] [Abstract][Full Text] [Related]
2. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
3. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
Filippatos TD; Tsimihodimos V; Derdemezis CS; Gazi IF; Saougos V; Mikhailidis DP; Tselepis AD; Elisaf MS
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):330-6. PubMed ID: 21963513
[TBL] [Abstract][Full Text] [Related]
5. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Oguz Y; Aslan I; Vural A; Yenicesu M; Stenvinkel P; Lindholm B; Axelsson J
Clin Transplant; 2009; 23(2):241-8. PubMed ID: 19402217
[TBL] [Abstract][Full Text] [Related]
6. The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis.
Aydoğan Baykara R; Küçük A; Tuzcu A; Tuzcu G; Cüre E; Uslu AU; Omma A
Turk J Med Sci; 2021 Aug; 51(4):1865-1874. PubMed ID: 33754654
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients.
Banerjee D; Recio-Mayoral A; Chitalia N; Kaski JC
Clin Cardiol; 2011 Jun; 34(6):360-5. PubMed ID: 21538390
[TBL] [Abstract][Full Text] [Related]
8. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.
Eyileten T; Sonmez A; Saglam M; Cakir E; Caglar K; Oguz Y; Vural A; Yenicesu M; Yilmaz MI
Nephrology (Carlton); 2010 Mar; 15(2):225-9. PubMed ID: 20470283
[TBL] [Abstract][Full Text] [Related]
9. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.
Carrero JJ; Witasp A; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Suliman ME; Anderstam B; Lindholm B; Nordfors L; Schalling M; Axelsson J
Nephrol Dial Transplant; 2010 Mar; 25(3):901-6. PubMed ID: 19948877
[TBL] [Abstract][Full Text] [Related]
10. Association between visfatin levels and coronary artery disease in patients with chronic kidney disease.
Lu YC; Hsu CC; Yu TH; Wang CP; Lu LF; Hung WC; Chiu CA; Chung FM; Lee YJ; Tsai IT
Iran J Kidney Dis; 2013 Nov; 7(6):446-52. PubMed ID: 24241090
[TBL] [Abstract][Full Text] [Related]
11. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
12. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
Ifrim S; Vasilescu R
Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
[TBL] [Abstract][Full Text] [Related]
13. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
14. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
[TBL] [Abstract][Full Text] [Related]
15. [Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness].
Carotti M; Salaffi F; Mangiacotti M; Cerioni A; Giuseppetti GM; Grassi W
Reumatismo; 2007; 59(1):38-49. PubMed ID: 17435841
[TBL] [Abstract][Full Text] [Related]
16. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
Nimkuntod P; Tongdee P
J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
[TBL] [Abstract][Full Text] [Related]
17. Young adults with coeliac disease may be at increased risk of early atherosclerosis.
De Marchi S; Chiarioni G; Prior M; Arosio E
Aliment Pharmacol Ther; 2013 Jul; 38(2):162-9. PubMed ID: 23730933
[TBL] [Abstract][Full Text] [Related]
18. CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.
Lamprea-Montealegre JA; Astor BC; McClelland RL; de Boer IH; Burke GL; Sibley CT; O'Leary D; Sharrett AR; Szklo M
Clin J Am Soc Nephrol; 2012 Nov; 7(11):1777-85. PubMed ID: 22879436
[TBL] [Abstract][Full Text] [Related]
19. Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis.
Hamed SA; Hamed EA; Ezz Eldin AM; Mahmoud NM
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):92-103. PubMed ID: 20189084
[TBL] [Abstract][Full Text] [Related]
20. Deterioration of endothelial function and carotid intima-media thickness in Tibetan male adolescents exposed to second-hand smoke.
Yang B; Li M; Chen B; Xu Y; Li TD
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):413-9. PubMed ID: 22465995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
